Menu Search
Equities

Zhong Ji Longevity Science Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
767:HKG.HS

Zhong Ji Longevity Science Group Ltd

Actions
  • Price (HKD)0.445
  • Today's Change-0.015 / -3.26%
  • Shares traded10.00k
  • 1 Year change+85.42%
  • Beta0.6412
Data delayed at least 15 minutes, as of Feb 16 2026 03:42 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Zhong Ji Longevity Science Group Ltd, formerly Asia Pacific Silk Road Investment Co Ltd, is an investment holding company principally engaged in the longevity science and money lending business. The Company mainly operates its business through five segments. The Longevity Science segment is engaged in longevity science research, longevity medical testing, longevity biological products, longevity management services and member division. The Money Lending segment is engaged in the money lending business and the provision of credits. The Securities and Other Investment segment is mainly engaged in the holding of equity investments and investment in short to long-term financial assets. The Property Investment segment is mainly engaged in the investment in properties for rental income and for potential capital appreciation. The Financial and Investment Advisory segment is mainly engaged in the provision of financial and investment consulting services.

  • Revenue in HKD (TTM)171.75m
  • Net income in HKD-46.28m
  • Incorporated1994
  • Employees52.00
  • Location
    Zhong Ji Longevity Science Group LtdRoom 1802,88 Gloucester RoadWanchai Hong KongHKG
  • Phone+852 25265778
  • Fax+852 25265733
  • Websitehttps://zhongji.com.hk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.